Who we are
We come from all around the world, bringing literally thousands of years of combined knowledge and expertise to our mission. We are specialists in biosimilar medicines creation, all along the value chain from cell line development to commercial manufacturing.
What we do
Our biosimilar assets include several biosimilar monoclonal antibodies and fusion proteins that are developed in our research & development centers located across Europe and are manufactured in our state-of-the-art facility in Reykjavik, Iceland.
We develop, produce and release our biosimilars in-house with the latest available technology and to the highest quality standards for the supply of finished and ready to commercialize products to our partners worldwide.
